Cargando…
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
AIMS: Previous studies on the cost-effectiveness of screening for atrial fibrillation (AF) are based on assumptions of long-term clinical effects. The STROKESTOP study, which randomised 27 975 persons aged 75/76 years into a screening invitation group and a control group, has a median follow-up time...
Autores principales: | Lyth, Johan, Svennberg, Emma, Bernfort, Lars, Aronsson, Mattias, Frykman, Viveka, Al-Khalili, Faris, Friberg, Leif, Rosenqvist, Mårten, Engdahl, Johan, Levin, Lars-Åke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839418/ https://www.ncbi.nlm.nih.gov/pubmed/36349968 http://dx.doi.org/10.1093/eurheartj/ehac547 |
Ejemplares similares
-
Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
por: Kemp Gudmundsdottir, Katrin, et al.
Publicado: (2020) -
Decentralising atrial fibrillation screening to overcome socio-demographic inequalities in uptake in STROKESTOP II
por: Gudmundsdottir, Katrin Kemp, et al.
Publicado: (2020) -
Brief episodes of rapid irregular atrial activity (micro-AF) are a risk marker for atrial fibrillation: a prospective cohort study
por: Fredriksson, Tove, et al.
Publicado: (2020) -
Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation—Compliance and ease of use in an ambulatory elderly population
por: Fredriksson, Tove, et al.
Publicado: (2020) -
Performance of pulse palpation compared to one‐lead ECG in atrial fibrillation screening
por: Gudmundsdottir, Katrin Kemp, et al.
Publicado: (2021)